Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Cancer Research|April 7, 2011
Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progressionMaya Zigler, Gabriel J Villares, Andrey S Dobroff, et al.
Cancer Biology & Therapy|April 30, 2008
EphA2 overexpression promotes ovarian cancer growthChunhua Lu, Mian M K Shahzad, Hua Wang, et al.
Cancer Research|November 1, 2008
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNAGabriel J Villares, Maya Zigler, Hua Wang, et al.
The Journal of Urology|November 17, 2007
Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancerWassim Kassouf, Peter C Black, Tomasz Tuziak, et al.
Cancer Research|July 4, 2003
Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathwaysWenbiao Liu, Niels Reinmuth, Oliver Stoeltzing, et al.
Cancer Research|February 12, 2005
The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivoElise Bales, Lisa Mills, Nancy Milam, et al.
The Journal of Biological Chemistry|August 26, 2009
Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasisVladislava O Melnikova, Krishnakumar Balasubramanian, Gabriel J Villares, et al.
Cancer Research|October 17, 2008
A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humansFernanda I Staquicini, Anita Tandle, Steven K Libutti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cellsPeter C Black, Gordon A Brown, Teruo Inamoto, et al.
Melanoma Research|July 9, 2011
A phase II study of gefitinib in patients with metastatic melanomaSapna P Patel, Kevin B Kim, Nicholas E Papadopoulos, et al.
Pageof 11